“…These epitopes are capable of eliciting the production of viral neutralizing antibodies against IPNV (Frost et al, 1995;Munang'Andu & Evensen, 2015). Vaccines encoding the recombinant VP2 gene had been shown to be sufficient to induce a protective immune response (Ahmadivand, Soltani, Behdani et al, 2017;Ahmadivand, Soltani, Mardani et al, 2017;Ballesteros, Saint-Jean, Encinas, Perez-Prieto, & Coll, 2012;Guo et al, 2018). A previous study showed that the truncated VP2 protein (147-307 amino acids) is capable of inducing an anti-IPNV antibody response with antibody titres similar to those for whole IPNV (Labus et al, 2001).…”